ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261610.1	Avagacestat	Bladder urothelial carcinoma	0.000594496	Resistant
ENSG00000261610.1	Avagacestat	Breast invasive carcinoma	0.025413277	Sensitive